SCHEMBL5675194

SCHEMBL5675194

Cc1ccc(-n2nc(C)c(N=Nc3c(O)cccc3C(=O)O)c2O)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPL P40238 1/20 0.42
▸ STAT1 P42224 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CA1 P00915 4/20 0.41
▸ CA2 P00918 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ LMNA P02545 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ PAX8 Q06710 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ DUSP3 P51452 2/20 0.38
▸ MYC P01106 1/20 0.38
▸ KLKB1 P03952 1/20 0.38
▸ CTSB P07858 1/20 0.38
▸ ELANE P08246 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5675193 1.00 MPL (0.42) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL7188373 0.87 MAPT (0.44) CYP1A2CYP2C19ALDH1A1LMNARAB9A
SCHEMBL5673425 0.87 MPL (0.44) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL5673730 0.87 MPL (0.44) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL7246023 0.84 MPL (0.62) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL7515436 0.83 MPL (0.44) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL5673412 0.81 LMNA (0.42) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL5673418 0.81 LMNA (0.42) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL5672426 0.81 LMNA (0.42) MPLSTAT1CYP1A2CYP2C19CA1
SCHEMBL5672419 0.81 LMNA (0.42) MPLSTAT1CYP1A2CYP2C19CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP claimed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US claimed
EP-1213965-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2003-05-02 — — EP claimed
EP-1213965-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2002-06-19 — — EP claimed
WO-2001017349-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BECKMAN CORPORATION (US) 2001-03-15 — — WO claimed
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP disclosed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US disclosed
EP-1213965-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2003-05-02 — — EP disclosed
EP-1213965-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2002-06-19 — — EP disclosed
WO-2001017349-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BECKMAN CORPORATION (US) 2001-03-15 — — WO disclosed
Send feedback